Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | San-Miguel, J.F. (Jesús F.) | - |
dc.date.accessioned | 2014-08-30T17:08:07Z | - |
dc.date.available | 2014-08-30T17:08:07Z | - |
dc.date.issued | 2014-01 | - |
dc.identifier.citation | San Miguel JF. Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment?. Haematologica. 2014 Jan;99(1):5-6 | es_ES |
dc.identifier.issn | 0390-6078 | - |
dc.identifier.uri | https://hdl.handle.net/10171/36415 | - |
dc.description.abstract | Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Ferrata Storti Foundation | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Bortezomib | es_ES |
dc.subject | Multiple myeloma | es_ES |
dc.subject | Humans | es_ES |
dc.subject | Antineoplastic agents | es_ES |
dc.title | Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment? | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.identifier.doi | http://dx.doi.org/10.3324/haematol.2013.100982 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.